OBJECTIVE: To determine the effects of dietary supplements containing bovine serum concentrate (BSC, a source of immunoglobulins) and/or multiple micronutrients (MMN) on children's growth velocity, rates of common infections, and MN status. DESIGN: Randomized, controlled, community-based intervention trial. SETTING: Low-income, peri-urban Guatemalan community. SUBJECTS:Children aged 6-7 months initially. INTERVENTIONS: Children received one of four maize-based dietary supplements daily for 8 months, containing: (1) BSC, (2) whey protein concentrate (WPC, control group), (3) WPC+MMN, or (4) BSC+MMN. RESULTS: There were no significant differences in growth or rates of morbidity by treatment group. Children who received MMN had lower rates of anemia and (in the group that received WPC+MMN) less of a decline in serum ferritin than those who did not, but there were no differences in other biochemical indicators of MN status by treatment group. CONCLUSIONS:MMN supplementation reduced anemia and iron deficiency in this population, but the MMN content and source of protein in the supplements did not affect other indicators of MN status, growth or morbidity.
RCT Entities:
OBJECTIVE: To determine the effects of dietary supplements containing bovine serum concentrate (BSC, a source of immunoglobulins) and/or multiple micronutrients (MMN) on children's growth velocity, rates of common infections, and MN status. DESIGN: Randomized, controlled, community-based intervention trial. SETTING: Low-income, peri-urban Guatemalan community. SUBJECTS:Children aged 6-7 months initially. INTERVENTIONS:Children received one of four maize-based dietary supplements daily for 8 months, containing: (1) BSC, (2) whey protein concentrate (WPC, control group), (3) WPC+MMN, or (4) BSC+MMN. RESULTS: There were no significant differences in growth or rates of morbidity by treatment group. Children who received MMN had lower rates of anemia and (in the group that received WPC+MMN) less of a decline in serum ferritin than those who did not, but there were no differences in other biochemical indicators of MN status by treatment group. CONCLUSIONS: MMN supplementation reduced anemia and iron deficiency in this population, but the MMN content and source of protein in the supplements did not affect other indicators of MN status, growth or morbidity.
Authors: Bryon W Petschow; Anthony T Blikslager; Eric M Weaver; Joy M Campbell; Javier Polo; Audrey L Shaw; Bruce P Burnett; Gerald L Klein; J Marc Rhoads Journal: World J Gastroenterol Date: 2014-09-07 Impact factor: 5.742
Authors: Ira Shafran; Patricia Burgunder; David Wei; Hayley E Young; Gerald Klein; Bruce P Burnett Journal: Therap Adv Gastroenterol Date: 2015-11 Impact factor: 4.409
Authors: Caitlin D French; Joanne E Arsenault; Charles D Arnold; Demewoz Haile; Hanqi Luo; Kevin W Dodd; Stephen A Vosti; Carolyn M Slupsky; Reina Engle-Stone Journal: Adv Nutr Date: 2021-03-31 Impact factor: 8.701
Authors: Christopher J Detzel; Alan Horgan; Abigail L Henderson; Bryon W Petschow; Christopher D Warner; Kenneth J Maas; Eric M Weaver Journal: PLoS One Date: 2015-04-01 Impact factor: 3.240
Authors: Matthew J Stotts; Amanda Cheung; Muhammad B Hammami; David J Westrich; Eric Anderson; Lauren Counts; Alex S Befeler; Adrian M Di Bisceglie; Charlene Prather Journal: Cureus Date: 2021-06-02